Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sonoma Pharmaceuticals Inc.

www.sonomapharma.com

Latest From Sonoma Pharmaceuticals Inc.

Medical Device Deals Update, May 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced March-April 2016.

Medical Device

Deal Watch: Valeant Increases Bid, Wrests Salix Away From Endo

Janssen moves into a new generation of anticoagulation with X01 buyout. Lilly obtains Phase II-ready autoimmune candidate from South Korea’s Hanmi, which partnered a cancer compound with Spectrum just a week earlier, while AstraZeneca finds a commercialization partner for Movantik in Japan’s Daiichi Sankyo.

BioPharmaceutical Deals

Deals Shaping The Medical Industry, February 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014-January 2015.

BioPharmaceutical Medical Device

Device Firms See No Correlation Between Series A And Exit

Large or small, Series A rounds in the device sector don’t have a statistical correlation with exit value, but there is some evidence that initial runway has some influence.

Medical Device Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • OTC, Consumer
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Infectious & Viral Diseases
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Oculus Innovative Sciences Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Sonoma Pharmaceuticals Inc.
  • Senior Management
  • Amy Trombly, Interim CEO
    John Dal Poggetto, CFO
  • Contact Info
  • Sonoma Pharmaceuticals Inc.
    Phone: (707) 283-0550
    1129 N. McDowell Blvd.
    Petaluma, CA 94954
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register